Search Results 911-920 of 18280 for Immunode

1. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

   Subjects may be tested for human immunodeficiency virus (HIV) prior to ... immunodeficiency syndrome-defining opportunistic infection within the past ...

2. SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction - Mayo Clinic

   Known active human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV) infection. Inactive hepatitis carrier status or low ...

3. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

   Are infected with human immunodeficiency virus (HIV);; QuantiFERON®-TB test or Purified Protein Derivative (PPD) skin test, or both, according to local ...

4. Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients with Relapsed or Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   Ongoing or active systemic infection, active hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive; Any serious medical or ...

5. Study of MLN4924 Plus Azacitidine in Treatment-Naïve Patients With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older - Mayo Clinic

   Known human immunodeficiency virus (HIV) positive; Known hepatitis B surface antigen-positive, or known or suspected active hepatitis C infection; Known ...

6. Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in NMIBC - Mayo Clinic

   * Significant immunodeficiency. * Pregnant or breastfeeding. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 1 ...

7. Pediatrics Clinical Trials - Medical Professionals

   These immune deficiency diseases are thought to be rare and include: Severe combined immunodeficiency (SCID), leukocyte adhesion deficiency (LAD), X-linked ...

8. Study of bb2121 in Multiple Myeloma - Clinical Trials

   Known human immunodeficiency virus (HIV) positivity. Subjects with a history of class III or IV congestive heart failure or non-ischemic cardiomyopathy ...

9. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors - Mayo Clinic

   Immunodeficiency or immunosuppression, including systemic corticosteroids at >10mg/day prednisone or equivalent within 1 week prior to planned start of ...

10. A Study Using Momelotinib in Transfusion-Dependent Adults with Primary Myelofibrosis, Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis - Mayo Clinic

    Prior splenectomy · Splenic irradiation within 3 months prior to the first dose of MMB · Prior treatment with MMB · Known positive status of human immunodeficiency ...